Episode 97 - Christina Coughlin - CEO Avacta Therapeutics

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d5/e4/1e/d5e41e47-bfe8-20ea-325b-c4cfd91dca77/mza_4324065226824686757.jpg/600x600bb.jpg

The BioHub: The Top Voices in Biotech

Max Brennan - Biotech HeadHunter

129 episodes

3 days ago

Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.

Life Sciences

Science

RSS

All content for The BioHub: The Top Voices in Biotech is the property of Max Brennan - Biotech HeadHunter and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1704904841978-1a5f9097fe03.jpg

Episode 97 - Christina Coughlin - CEO Avacta Therapeutics

The BioHub: The Top Voices in Biotech

30 minutes 35 seconds

2 weeks ago

Episode 97 - Christina Coughlin - CEO Avacta Therapeutics

We were delighted to welcome Dr. Christina Coughlin, CEO of Avacta Therapeutics, onto The BioHub! Avacta are a clinical-stage biotech pioneering next-generation oncology therapies.

With a remarkable career spanning top pharmaceutical companies and cutting-edge biotech — from Immunocore and Rubius Therapeutics to Tmunity and CytoImmune — Christina brings a unique blend of medical expertise, scientific insight, and leadership acumen. At Avacta, she is driving the development of groundbreaking therapeutics, leveraging proprietary platforms like pre|CISION™, with the goal of bringing life-changing treatments from lab to clinic.

In this episode, we’ll explore her journey from clinician-scientist to biotech executive, the vision and science behind Avacta, and the challenges and opportunities in developing innovative cancer therapies in today’s evolving regulatory and commercial landscape.